Nutrition in inflammatory bowel disease: new trends.

IF 3.5 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Current Opinion in Clinical Nutrition and Metabolic Care Pub Date : 2025-09-01 Epub Date: 2025-07-07 DOI:10.1097/MCO.0000000000001140

Nathan Kuk, Chu K Yao, Ashish R Srinivasan, Abhinav Vasudevan

{"title":"Nutrition in inflammatory bowel disease: new trends.","authors":"Nathan Kuk, Chu K Yao, Ashish R Srinivasan, Abhinav Vasudevan","doi":"10.1097/MCO.0000000000001140","DOIUrl":null,"url":null,"abstract":"Purpose of review: This review examines the latest evidence and highlights the importance of personalized dietary therapies to augment conventional medical treatments in the treatment of inflammatory bowel disease.Recent findings: Diversity in the maternal diet may reduce the risk of development of ulcerative colitis in utero, while a diverse diet during childhood may reduce the risk of future inflammatory bowel disease. During adulthood, the Mediterranean diet (MED) and Diet A Stop Hypertension may reduce the risk of developing inflammatory bowel disease, with some evidence to support that anthocyanin intake is a beneficial component of the diet. For dietary therapy for the maintenance of remission in Crohn's disease, it appears that the MED and simple carbohydrate diet and variations of this diet may be beneficial, although more trials are needed to confirm this.Summary: the role of diet in preventing inflammatory bowel disease and treating symptoms continues to evolve and dietary changes may be considered in addition to medical therapy in the treatment of inflammatory bowel disease.","PeriodicalId":10962,"journal":{"name":"Current Opinion in Clinical Nutrition and Metabolic Care","volume":" ","pages":"410-421"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Clinical Nutrition and Metabolic Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MCO.0000000000001140","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: This review examines the latest evidence and highlights the importance of personalized dietary therapies to augment conventional medical treatments in the treatment of inflammatory bowel disease.

Recent findings: Diversity in the maternal diet may reduce the risk of development of ulcerative colitis in utero, while a diverse diet during childhood may reduce the risk of future inflammatory bowel disease. During adulthood, the Mediterranean diet (MED) and Diet A Stop Hypertension may reduce the risk of developing inflammatory bowel disease, with some evidence to support that anthocyanin intake is a beneficial component of the diet. For dietary therapy for the maintenance of remission in Crohn's disease, it appears that the MED and simple carbohydrate diet and variations of this diet may be beneficial, although more trials are needed to confirm this.

Summary: the role of diet in preventing inflammatory bowel disease and treating symptoms continues to evolve and dietary changes may be considered in addition to medical therapy in the treatment of inflammatory bowel disease.

查看原文本刊更多论文

炎症性肠病的营养：新趋势。

综述目的：本综述回顾了最新的证据，并强调了个性化饮食疗法在炎症性肠病治疗中增强传统医学治疗的重要性。最近的研究发现：产妇饮食的多样性可能会降低子宫内溃疡性结肠炎的风险，而儿童时期的多样化饮食可能会降低未来炎症性肠病的风险。在成年期，地中海饮食（MED）和饮食A停止高血压可以降低患炎症性肠病的风险，一些证据支持花青素摄入是饮食中有益的组成部分。对于维持克罗恩病缓解的饮食疗法，MED和简单碳水化合物饮食以及这种饮食的变化可能是有益的，尽管需要更多的试验来证实这一点。总结：饮食在预防炎症性肠病和治疗症状方面的作用不断发展，除了药物治疗外，还可以考虑改变饮食来治疗炎症性肠病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Opinion in Clinical Nutrition and Metabolic Care 医学-内分泌学与代谢

CiteScore

5.30

自引率

6.50%

发文量

116

审稿时长

6-12 weeks

期刊介绍： A high impact review journal which boasts an international readership, Current Opinion in Clinical Nutrition and Metabolic Care offers a broad-based perspective on the most recent and exciting developments within the field of clinical nutrition and metabolic care. Published bimonthly, each issue features insightful editorials and high quality invited reviews covering two or three key disciplines which include protein, amino acid metabolism and therapy, lipid metabolism and therapy, nutrition and the intensive care unit and carbohydrates. Each discipline introduces world renowned guest editors to ensure the journal is at the forefront of knowledge development and delivers balanced, expert assessments of advances from the previous year.